The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microneedles for Vaccination Market Research Report 2024
Synopsis
Global Microneedles for Vaccination market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Microneedles for Vaccination market research.
Key manufacturers engaged in the Microneedles for Vaccination industry include 3M, Zosano Pharma Corporation, Vaxxas Pty Ltd, Micron Biomedical, Inc., Nanopass Technologies Ltd., Corium International, Inc., Theraject, Inc., Valeritas, Inc. and Lohmann Therapie-systeme Ag, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Microneedles for Vaccination were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Microneedles for Vaccination market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Microneedles for Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
3M
Zosano Pharma Corporation
Vaxxas Pty Ltd
Micron Biomedical, Inc.
Nanopass Technologies Ltd.
Corium International, Inc.
Theraject, Inc.
Valeritas, Inc.
Lohmann Therapie-systeme Ag
Microdermics Inc.
Segment by Type
Silicon Microneedles
Polymer Microneedles
Metal Microneedles
Ceramic Microneedles
Others
Segment by Application
Hospitals and Clinics
Research Institutions
Pharmaceutical Companies
Vaccination Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Microneedles for Vaccination report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Microneedles for Vaccination market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Microneedles for Vaccination market research.
Key manufacturers engaged in the Microneedles for Vaccination industry include 3M, Zosano Pharma Corporation, Vaxxas Pty Ltd, Micron Biomedical, Inc., Nanopass Technologies Ltd., Corium International, Inc., Theraject, Inc., Valeritas, Inc. and Lohmann Therapie-systeme Ag, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Microneedles for Vaccination were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Microneedles for Vaccination market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Microneedles for Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
3M
Zosano Pharma Corporation
Vaxxas Pty Ltd
Micron Biomedical, Inc.
Nanopass Technologies Ltd.
Corium International, Inc.
Theraject, Inc.
Valeritas, Inc.
Lohmann Therapie-systeme Ag
Microdermics Inc.
Segment by Type
Silicon Microneedles
Polymer Microneedles
Metal Microneedles
Ceramic Microneedles
Others
Segment by Application
Hospitals and Clinics
Research Institutions
Pharmaceutical Companies
Vaccination Centers
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Microneedles for Vaccination report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Microneedles for Vaccination Market Overview
1.1 Product Overview and Scope of Microneedles for Vaccination
1.2 Microneedles for Vaccination Segment by Type
1.2.1 Global Microneedles for Vaccination Market Value Comparison by Type (2023-2029)
1.2.2 Silicon Microneedles
1.2.3 Polymer Microneedles
1.2.4 Metal Microneedles
1.2.5 Ceramic Microneedles
1.2.6 Others
1.3 Microneedles for Vaccination Segment by Application
1.3.1 Global Microneedles for Vaccination Market Value by Application: (2023-2029)
1.3.2 Hospitals and Clinics
1.3.3 Research Institutions
1.3.4 Pharmaceutical Companies
1.3.5 Vaccination Centers
1.4 Global Microneedles for Vaccination Market Size Estimates and Forecasts
1.4.1 Global Microneedles for Vaccination Revenue 2018-2029
1.4.2 Global Microneedles for Vaccination Sales 2018-2029
1.4.3 Global Microneedles for Vaccination Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Microneedles for Vaccination Market Competition by Manufacturers
2.1 Global Microneedles for Vaccination Sales Market Share by Manufacturers (2018-2023)
2.2 Global Microneedles for Vaccination Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Microneedles for Vaccination Average Price by Manufacturers (2018-2023)
2.4 Global Microneedles for Vaccination Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Microneedles for Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedles for Vaccination, Product Type & Application
2.7 Microneedles for Vaccination Market Competitive Situation and Trends
2.7.1 Microneedles for Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microneedles for Vaccination Players Market Share by Revenue
2.7.3 Global Microneedles for Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microneedles for Vaccination Retrospective Market Scenario by Region
3.1 Global Microneedles for Vaccination Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Microneedles for Vaccination Global Microneedles for Vaccination Sales by Region: 2018-2029
3.2.1 Global Microneedles for Vaccination Sales by Region: 2018-2023
3.2.2 Global Microneedles for Vaccination Sales by Region: 2024-2029
3.3 Global Microneedles for Vaccination Global Microneedles for Vaccination Revenue by Region: 2018-2029
3.3.1 Global Microneedles for Vaccination Revenue by Region: 2018-2023
3.3.2 Global Microneedles for Vaccination Revenue by Region: 2024-2029
3.4 North America Microneedles for Vaccination Market Facts & Figures by Country
3.4.1 North America Microneedles for Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Microneedles for Vaccination Sales by Country (2018-2029)
3.4.3 North America Microneedles for Vaccination Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microneedles for Vaccination Market Facts & Figures by Country
3.5.1 Europe Microneedles for Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Microneedles for Vaccination Sales by Country (2018-2029)
3.5.3 Europe Microneedles for Vaccination Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedles for Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Microneedles for Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Microneedles for Vaccination Sales by Country (2018-2029)
3.6.3 Asia Pacific Microneedles for Vaccination Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Microneedles for Vaccination Market Facts & Figures by Country
3.7.1 Latin America Microneedles for Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Microneedles for Vaccination Sales by Country (2018-2029)
3.7.3 Latin America Microneedles for Vaccination Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Microneedles for Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Microneedles for Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Microneedles for Vaccination Sales by Country (2018-2029)
3.8.3 Middle East and Africa Microneedles for Vaccination Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microneedles for Vaccination Sales by Type (2018-2029)
4.1.1 Global Microneedles for Vaccination Sales by Type (2018-2023)
4.1.2 Global Microneedles for Vaccination Sales by Type (2024-2029)
4.1.3 Global Microneedles for Vaccination Sales Market Share by Type (2018-2029)
4.2 Global Microneedles for Vaccination Revenue by Type (2018-2029)
4.2.1 Global Microneedles for Vaccination Revenue by Type (2018-2023)
4.2.2 Global Microneedles for Vaccination Revenue by Type (2024-2029)
4.2.3 Global Microneedles for Vaccination Revenue Market Share by Type (2018-2029)
4.3 Global Microneedles for Vaccination Price by Type (2018-2029)
5 Segment by Application
5.1 Global Microneedles for Vaccination Sales by Application (2018-2029)
5.1.1 Global Microneedles for Vaccination Sales by Application (2018-2023)
5.1.2 Global Microneedles for Vaccination Sales by Application (2024-2029)
5.1.3 Global Microneedles for Vaccination Sales Market Share by Application (2018-2029)
5.2 Global Microneedles for Vaccination Revenue by Application (2018-2029)
5.2.1 Global Microneedles for Vaccination Revenue by Application (2018-2023)
5.2.2 Global Microneedles for Vaccination Revenue by Application (2024-2029)
5.2.3 Global Microneedles for Vaccination Revenue Market Share by Application (2018-2029)
5.3 Global Microneedles for Vaccination Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3M Microneedles for Vaccination Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Zosano Pharma Corporation
6.2.1 Zosano Pharma Corporation Corporation Information
6.2.2 Zosano Pharma Corporation Description and Business Overview
6.2.3 Zosano Pharma Corporation Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zosano Pharma Corporation Microneedles for Vaccination Product Portfolio
6.2.5 Zosano Pharma Corporation Recent Developments/Updates
6.3 Vaxxas Pty Ltd
6.3.1 Vaxxas Pty Ltd Corporation Information
6.3.2 Vaxxas Pty Ltd Description and Business Overview
6.3.3 Vaxxas Pty Ltd Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Vaxxas Pty Ltd Microneedles for Vaccination Product Portfolio
6.3.5 Vaxxas Pty Ltd Recent Developments/Updates
6.4 Micron Biomedical, Inc.
6.4.1 Micron Biomedical, Inc. Corporation Information
6.4.2 Micron Biomedical, Inc. Description and Business Overview
6.4.3 Micron Biomedical, Inc. Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Micron Biomedical, Inc. Microneedles for Vaccination Product Portfolio
6.4.5 Micron Biomedical, Inc. Recent Developments/Updates
6.5 Nanopass Technologies Ltd.
6.5.1 Nanopass Technologies Ltd. Corporation Information
6.5.2 Nanopass Technologies Ltd. Description and Business Overview
6.5.3 Nanopass Technologies Ltd. Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Nanopass Technologies Ltd. Microneedles for Vaccination Product Portfolio
6.5.5 Nanopass Technologies Ltd. Recent Developments/Updates
6.6 Corium International, Inc.
6.6.1 Corium International, Inc. Corporation Information
6.6.2 Corium International, Inc. Description and Business Overview
6.6.3 Corium International, Inc. Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Corium International, Inc. Microneedles for Vaccination Product Portfolio
6.6.5 Corium International, Inc. Recent Developments/Updates
6.7 Theraject, Inc.
6.6.1 Theraject, Inc. Corporation Information
6.6.2 Theraject, Inc. Description and Business Overview
6.6.3 Theraject, Inc. Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Theraject, Inc. Microneedles for Vaccination Product Portfolio
6.7.5 Theraject, Inc. Recent Developments/Updates
6.8 Valeritas, Inc.
6.8.1 Valeritas, Inc. Corporation Information
6.8.2 Valeritas, Inc. Description and Business Overview
6.8.3 Valeritas, Inc. Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Valeritas, Inc. Microneedles for Vaccination Product Portfolio
6.8.5 Valeritas, Inc. Recent Developments/Updates
6.9 Lohmann Therapie-systeme Ag
6.9.1 Lohmann Therapie-systeme Ag Corporation Information
6.9.2 Lohmann Therapie-systeme Ag Description and Business Overview
6.9.3 Lohmann Therapie-systeme Ag Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lohmann Therapie-systeme Ag Microneedles for Vaccination Product Portfolio
6.9.5 Lohmann Therapie-systeme Ag Recent Developments/Updates
6.10 Microdermics Inc.
6.10.1 Microdermics Inc. Corporation Information
6.10.2 Microdermics Inc. Description and Business Overview
6.10.3 Microdermics Inc. Microneedles for Vaccination Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Microdermics Inc. Microneedles for Vaccination Product Portfolio
6.10.5 Microdermics Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedles for Vaccination Industry Chain Analysis
7.2 Microneedles for Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedles for Vaccination Production Mode & Process
7.4 Microneedles for Vaccination Sales and Marketing
7.4.1 Microneedles for Vaccination Sales Channels
7.4.2 Microneedles for Vaccination Distributors
7.5 Microneedles for Vaccination Customers
8 Microneedles for Vaccination Market Dynamics
8.1 Microneedles for Vaccination Industry Trends
8.2 Microneedles for Vaccination Market Drivers
8.3 Microneedles for Vaccination Market Challenges
8.4 Microneedles for Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
